Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Kenmore › NPI 1770598104
Hospital

Kenmore Mercy Hospital

Kenmore Mercy Hospital was paid $17.54M by Medicaid between Jan 2018 and Dec 2024, across 203 billing codes. Its largest line is 99284, emergency room visit (serious) — 23% of everything it billed.

33Billing provider infoKENMORE MERCY HOSPITAL
KENMORE, NY 14217
33aNPI1770598104assigned 07/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$17.54M
24GClaims480,386
24DCodes billed203
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#66 of 231
Median peer was paid$561K
This provider vs. median31×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20187,019$185K
201934,734$1.04M
202070,554$2.58M
202187,565$3.27M
202292,807$3.50M
2023104,311$4.02M
2024incomplete83,396$2.93M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 23% 18,655 17,543 $4.11M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 19% 17,554 16,394 $3.28M
G0378 Hospital observation service, per hour 7.3% 1,422 864 $1.28M
96361 Intravenous infusion, hydration; each additional hour 6.9% 8,250 7,386 $1.21M
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 4.7% 722 622 $821K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.6% 3,122 3,050 $626K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.3% 3,688 3,531 $574K
36415 Collection of venous blood by venipuncture 3.2% 78,744 29,223 $553K
70450 Computed tomography, head or brain; without contrast material 3.0% 2,610 2,561 $523K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.2% 2,015 1,971 $390K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.9% 1,581 1,545 $335K
C1776 Joint device (implantable) 1.8% 106 87 $314K
191 more codes
76700 Ultrasound, abdominal, real time with image documentation; complete 1.7% 1,408 $304K
80053 Comprehensive metabolic panel 1.6% 21,396 $282K
93976 1.5% 1,088 $256K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.3% 2,401 $223K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.1% 5,166 $193K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,485 $156K
71275 Computed tomographic angiography, chest, with contrast material <1% 710 $147K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 4,476 $146K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 483 $140K
99213 Doctor's office visit, returning patient (routine) <1% 3,056 $111K
80048 Basic metabolic panel (calcium, ionized) <1% 7,148 $103K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 12,906 $94K
99214 Doctor's office visit, returning patient (more involved) <1% 1,792 $92K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,565 $83K
97161 <1% 1,348 $73K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 544 $63K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 797 $59K
77067 Screening mammography, bilateral, including computer-aided detection <1% 978 $55K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 16,880 $54K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,403 $41K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,721 $39K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,860 $38K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,437 $37K
87631 <1% 901 $35K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,292 $35K
83880 <1% 1,675 $34K
86850 <1% 1,642 $28K
97010 <1% 1,587 $25K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,458 $24K
93975 <1% 77 $24K
84443 Thyroid stimulating hormone (TSH) <1% 2,900 $22K
76830 Ultrasound, transvaginal <1% 929 $22K
81025 <1% 8,548 $20K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,191 $19K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 11,430 $19K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,769 $19K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 217 $17K
93971 <1% 405 $17K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 258 $17K
80061 Lipid panel <1% 2,883 $17K
71046 Radiologic examination, chest; 2 views <1% 3,362 $16K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 1,248 $16K
86900 <1% 1,718 $16K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 227 $16K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 26,106 $15K
83036 Hemoglobin; glycosylated (A1C) <1% 1,738 $14K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 716 $14K
82803 <1% 780 $13K
12001 <1% 27 $9K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 68 $9K
84439 <1% 1,223 $9K
71045 Radiologic examination, chest; single view <1% 6,719 $9K
80076 <1% 1,077 $9K
82607 <1% 793 $9K
72125 Computed tomography, cervical spine; without contrast material <1% 305 $8K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 117 $8K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 139 $8K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 801 $8K
85610 <1% 6,384 $8K
85730 <1% 5,797 $7K
97162 <1% 113 $7K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 275 $5K
10060 <1% 30 $5K
81001 <1% 8,984 $5K
86901 <1% 361 $4K
72131 <1% 25 $4K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,405 $4K
70551 Magnetic resonance imaging, brain; without contrast material <1% 12 $4K
85027 <1% 2,825 $4K
82948 <1% 2,568 $4K
86701 <1% 402 $3K
96375 Therapeutic injection; each additional sequential IV push <1% 8,210 $3K
97165 <1% 51 $3K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 814 $3K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 40 $3K
82746 <1% 287 $3K
76641 <1% 90 $3K
99000 <1% 252 $3K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 94 $3K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 24 $3K
84702 <1% 893 $2K
73630 <1% 779 $2K
90714 <1% 93 $2K
90472 Immunization administration, each additional vaccine (list separately) <1% 335 $2K
72100 <1% 404 $2K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 148 $2K
81003 <1% 4,275 $2K
83735 <1% 5,878 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,511 $2K
71271 <1% 53 $2K
73030 <1% 399 $1K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 13 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,128 $1K
99385 <1% 15 $1K
82043 <1% 271 $1K
76536 <1% 39 $1K
84484 <1% 8,782 $1K
72110 <1% 139 $1K
93979 <1% 17 $869.36
73562 <1% 211 $767.31
88304 <1% 65 $764.04
83690 <1% 7,897 $747.08
73130 <1% 429 $685.60
87040 <1% 2,407 $645.69
73610 <1% 472 $634.38
87660 <1% 571 $625.82
J1170 Injection, hydromorphone, up to 4 mg <1% 3,866 $616.38
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 78 $612.74
73564 <1% 150 $611.96
J3490 Unclassified drugs <1% 1,556 $547.38
82150 <1% 3,261 $521.66
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 14 $517.45
73502 <1% 238 $512.67
87077 <1% 1,333 $503.88
93041 <1% 1,683 $490.24
90686 <1% 35 $475.59
87186 <1% 1,189 $459.79
85652 <1% 406 $437.32
83605 <1% 2,275 $432.92
99406 <1% 41 $421.22
87070 <1% 627 $386.59
J0690 Injection, cefazolin sodium, 500 mg <1% 1,641 $341.87
J7030 Infusion, normal saline solution , 1000 cc <1% 7,420 $338.12
90715 <1% 15 $317.02
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,159 $314.23
72040 <1% 54 $270.91
97116 <1% 18 $248.00
85379 <1% 1,471 $246.79
87081 <1% 539 $217.86
87563 <1% 14 $217.63
86140 <1% 81 $216.77
90658 <1% 16 $194.88
84153 <1% 12 $186.45
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 376 $176.65
82570 <1% 42 $161.10
J2704 Injection, propofol, 10 mg <1% 1,578 $160.72
85007 <1% 848 $153.19
86803 <1% 89 $151.90
J7050 Infusion, normal saline solution, 250 cc <1% 803 $139.01
J3370 Injection, vancomycin hcl, 500 mg <1% 251 $134.00
73110 <1% 56 $120.15
96376 <1% 1,592 $114.29
97535 Self-care/home management training, each 15 minutes <1% 14 $100.15
A9270 Non-covered item or service <1% 9,757 $99.23
82550 <1% 139 $91.44
86780 <1% 13 $89.34
81015 <1% 629 $86.91
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 7,615 $83.05
C9113 Injection, pantoprazole sodium, per vial <1% 798 $80.56
83550 <1% 14 $61.06
84460 <1% 14 $60.82
84450 <1% 13 $58.04
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 353 $55.45
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,637 $50.83
87205 <1% 458 $50.71
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,400 $38.03
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,723 $37.30
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,309 $32.31
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,771 $26.83
95806 <1% 12 $25.67
80320 <1% 509 $25.10
73590 <1% 14 $24.24
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,377 $23.79
J3475 Injection, magnesium sulfate, per 500 mg <1% 434 $21.20
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,816 $15.11
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 123 $9.30
J7060 5% dextrose/water (500 ml = 1 unit) <1% 226 $9.07
94760 <1% 127 $6.89
86308 <1% 14 $4.73
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 527 $3.98
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 720 $2.49
J2060 Injection, lorazepam, 2 mg <1% 461 $2.00
J1644 Injection, heparin sodium, per 1000 units <1% 231 $1.77
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 31 $1.27
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 55 $0.20
80179 0% 64 $0.00
99080 0% 1,225 $0.00
82010 0% 27 $0.00
J0132 Injection, acetylcysteine, 100 mg 0% 144 $0.00
81513 0% 17 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 16 $0.00
90734 0% 18 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 0% 61 $0.00
90633 0% 40 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 41 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 128 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 0% 14 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 81 $0.00
80329 0% 187 $0.00
87590 0% 17 $0.00
90620 0% 35 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDUNLOP, JAMES (SENIOR VP & CFO)